- Home
- BNTX vs EXPE Comparison
BNTX vs EXPE Comparison
Compare BNTX & EXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | EXPE |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 35.4B |
| IPO Year | 2019 | 1999 |
Fundamental Metrics
Financial Performance| Metric | BNTX | EXPE |
|---|---|---|
| Price | $96.57 | $282.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 27 |
| Target Price | $137.40 | ★ $259.80 |
| AVG Volume (30 Days) | 1.4M | ★ 1.5M |
| Earning Date | 11-03-2025 | 02-05-2026 |
| Dividend Yield | N/A | ★ 0.56% |
| EPS Growth | N/A | ★ 35.97 |
| EPS | N/A | ★ 10.37 |
| Revenue | $3,698,814,972.00 | ★ $14,370,000,000.00 |
| Revenue This Year | $2.03 | $8.72 |
| Revenue Next Year | N/A | $7.18 |
| P/E Ratio | ★ N/A | $27.32 |
| Revenue Growth | 3.70 | ★ 7.29 |
| 52 Week Low | $81.20 | $130.01 |
| 52 Week High | $129.27 | $292.42 |
Technical Indicators
Market Signals| Indicator | BNTX | EXPE |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 60.03 |
| Support Level | $94.00 | $286.15 |
| Resistance Level | $95.71 | $288.13 |
| Average True Range (ATR) | 1.72 | 5.51 |
| MACD | 0.62 | -1.51 |
| Stochastic Oscillator | 81.33 | 47.65 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About EXPE Expedia Group Inc.
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and alternative accommodations brand Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.